We extracted data from observational studies, and the factors included age, gender, CD4 T-cell count, HIV viral load, comorbidities, days after complete vaccination, and vaccine type and were evaluated with respect to the seroconversion rate in PLWH after COVID-19 vaccination. This evidence concerns the gene CD4 and COVID-19.